Form 4 holding
Chief Medical Officer and Head of Research & Development.
Voyager Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 120,509
- Estimated value
- $861,639
- Report date
- 21 May 2021
- Price
- $7.15
- Ownership
- Direct